Answers are grounded in this paper and cite their sources.
Accurately differentiating between gastric gastrointestinal stromal tumors (GISTs) and leiomyomas before surgery holds great importance due to their divergent malignant potential; however, conventional endoscopic ultrasonography (EUS) has inherent limitations, especially for lesions under 2 cm. In this retrospective study involving 408 patients (198 GISTs and 210 leiomyomas) with gastric submucosal tumors (< 2 cm), a novel deep learning-radiomics (DLR) signature was developed via feature-level early fusion, concatenating compressed deep features from a pre-trained MobileNet_v2 with handcrafted radiomics features, followed by joint feature selection. This DLR signature was integrated with independently identified clinical factors to construct a combined nomogram. The proposed combined nomogram exhibited better diagnostic performance, and the test AUC was 0.901 (95% CI 0.846–0.956), while accuracy, sensitivity, and specificity were 0.846, 0.833, and 0.857, respectively, significantly outperforming the standalone radiomics (AUC = 0.822), deep transfer learning (DTL; AUC = 0.820), DLR (AUC = 0.860), and clinical (AUC = 0.724) signatures (DeLong test; all p < 0.05). The model showed excellent calibration and the greatest net clinical benefit among various threshold probabilities on decision curve analysis. This multimodal AI-driven nomogram provides a non-invasive tool for accurately differentiating gastric GISTs from leiomyomas in lesions smaller than 2 cm, with the ability to guide personalized management and reduce unnecessary invasive procedures.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: